Insurance Denials Meet Their Match in AI-Powered Appeals

• Claimable charges $50 per case and has raised $10 million from investors including Mark Cuban, with reported success in reversing 3 out of 4 denials
• The company has signed four deals with pharmaceutical manufacturers and is exploring a litigation arm for class-action suits against insurers showing patterns of wrongful denials
• Nonprofit Counterforce offers free AI-generated appeals and copies state regulators on filings, with some practices reporting same-day and next-day approvals after switching from manual appeals

Summary: Insurance Denials Meet Their Match in AI-Powered Appeals

Key Development:

AI-powered startups are disrupting the healthcare insurance appeals process, automating claim denials challenges with unprecedented speed and success rates. These platforms position themselves as intermediaries between insurers and patients in what was traditionally a two-party system.

Main Companies & Players:

• Claimable: Co-founded in 2023, raised $10 million from investors including Mark Cuban. Charges $50 per case and reports 75% success rate in reversing denials. Currently handles appeals for 28 conditions and 90 treatments.
• Counterforce: Nonprofit offering free AI-generated appeal letters, copying state regulators on filings to flag denial patterns.
• CVS Health: Facing potential class action after denying Zepbound weight-loss drug prescriptions in favor of competitors.

Market Context:

Fewer than 1% of patients currently appeal denied claims, with insurers upholding original denials over 50% of the time. This gap represents significant market opportunity.

Business Model Evolution:

While starting consumer-focused, Claimable is pivoting to enterprise deals with pharmaceutical manufacturers and hospital systems—four drugmaker agreements already signed. The direct-to-consumer model alone lacks scalability; enterprise volume drives viability. The company is exploring a litigation arm for class-action suits against systematic wrongful denials.

Technology:

Large language models trained on insurance laws, legal precedents, and medical literature generate customized appeals. Systems use curated knowledge sets to prevent AI hallucinations, though this limits speed and scope.

Market Implications:

This represents a structural shift in healthcare claims management, with AI arms race intensifying on both sides—insurers deploying AI for faster denials and fraud detection, while patient-focused tools automate appeals at scale.